MDM2 and breast carcinoma: Poor survival rate of mut TP53/high MDM2 breast cancer patients is not only correlated with the high expression level of DNAJB1/HSP40 molecular chaperone but also with high expression profile of other member of the DNAJ family, namely DNAJB6 [83] (Table 1).